MedPath

A Phase I/II trial of radical carbon-ion radiotherapy using 4 fractions for the patients with low- or intermediate-risk prostate cancer

Phase 1
Conditions
Prostate cancer
Registration Number
JPRN-UMIN000032340
Lead Sponsor
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Other therapies except for hormonal therapy 2) Previous radiation therapy to the pelvis 3) Ineligible dose constraints of risk organs 4) Castration resistant prostate cancer 5) Previous TUR-P 6) Active Double cancer 7) Presence of active double cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath